Amplifon Past Earnings Performance
Past criteria checks 2/6
Amplifon has been growing earnings at an average annual rate of 12.1%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 9.1% per year. Amplifon's return on equity is 13.9%, and it has net margins of 6.6%.
Key information
12.1%
Earnings growth rate
12.0%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 9.1% |
| Return on equity | 13.9% |
| Net Margin | 6.6% |
| Next Earnings Update | 06 Mar 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Amplifon makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,360 | 156 | 16 | 0 |
| 30 Jun 24 | 2,324 | 162 | 16 | 0 |
| 31 Mar 24 | 2,293 | 161 | 16 | 0 |
| 31 Dec 23 | 2,260 | 155 | 16 | 0 |
| 30 Sep 23 | 2,224 | 166 | 12 | 0 |
| 30 Jun 23 | 2,196 | 174 | 12 | 0 |
| 31 Mar 23 | 2,164 | 177 | 12 | 0 |
| 31 Dec 22 | 2,119 | 179 | 12 | 0 |
| 30 Sep 22 | 2,108 | 179 | 11 | 0 |
| 30 Jun 22 | 2,053 | 174 | 11 | 0 |
| 31 Mar 22 | 2,015 | 171 | 11 | 0 |
| 31 Dec 21 | 1,948 | 164 | 11 | 0 |
| 30 Sep 21 | 1,841 | 155 | 9 | 0 |
| 30 Jun 21 | 1,821 | 159 | 9 | 0 |
| 31 Mar 21 | 1,568 | 114 | 9 | 0 |
| 31 Dec 20 | 1,503 | 97 | 9 | 0 |
| 30 Sep 20 | 1,549 | 88 | 10 | 0 |
| 30 Jun 20 | 1,514 | 67 | 10 | 0 |
| 31 Mar 20 | 1,704 | 96 | 10 | 0 |
| 31 Dec 19 | 1,732 | 109 | 10 | 0 |
| 30 Sep 19 | 1,624 | 104 | 75 | 0 |
| 30 Jun 19 | 1,535 | 108 | 75 | 0 |
| 31 Mar 19 | 1,445 | 104 | 75 | 0 |
| 31 Dec 18 | 1,362 | 100 | 75 | 0 |
| 30 Sep 18 | 1,327 | 110 | 71 | 0 |
| 30 Jun 18 | 1,302 | 110 | 71 | 0 |
| 31 Mar 18 | 1,279 | 102 | 71 | 0 |
| 31 Dec 17 | 1,266 | 101 | 71 | 0 |
| 30 Sep 17 | 1,231 | 72 | 60 | 0 |
| 30 Jun 17 | 1,213 | 72 | 60 | 0 |
| 31 Mar 17 | 1,175 | 68 | 60 | 0 |
| 31 Dec 16 | 1,133 | 64 | 60 | 0 |
| 30 Sep 16 | 1,104 | 61 | 55 | 0 |
| 30 Jun 16 | 1,078 | 58 | 55 | 0 |
| 31 Mar 16 | 1,057 | 52 | 55 | 0 |
| 31 Dec 15 | 1,034 | 47 | 55 | 0 |
| 30 Sep 15 | 1,001 | 46 | 49 | 0 |
| 30 Jun 15 | 975 | 42 | 49 | 0 |
| 31 Mar 15 | 934 | 40 | 49 | 0 |
| 31 Dec 14 | 891 | 46 | 49 | 0 |
| 30 Sep 14 | 864 | 40 | -144 | 0 |
| 30 Jun 14 | 835 | 31 | -81 | 0 |
| 31 Mar 14 | 826 | 25 | -17 | 0 |
| 31 Dec 13 | 827 | 13 | 48 | 0 |
Quality Earnings: 0N61 has high quality earnings.
Growing Profit Margin: 0N61's current net profit margins (6.6%) are lower than last year (7.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0N61's earnings have grown by 12.1% per year over the past 5 years.
Accelerating Growth: 0N61's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 0N61 had negative earnings growth (-6.4%) over the past year, making it difficult to compare to the Healthcare industry average (14.3%).
Return on Equity
High ROE: 0N61's Return on Equity (13.9%) is considered low.